ruxolitinib
incyte,novartis
['jakafi']
patients with myelofibrosis who took jakafi had an improvement in their spleen volume and overall tumor symptom score, regardless of their anemia or transfusion status, research from #eha23 found. 
Cancer updates, research and education for patients with cancer, survivors and their caregivers to become empowered advocates in their journey.